Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis
Abstract Background Nosocomial infections are among the most common complications in hospitals. A major part is caused by multidrug-resistant organisms (MDRO). MRSA is still the most prominent and frequent MDRO. The early detection of carriers of multidrug-resistant bacteria is an effective measure...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-11-01
|
| Series: | Antimicrobial Resistance and Infection Control |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13756-018-0442-x |
| _version_ | 1828813690493730816 |
|---|---|
| author | Luise Hutzschenreuter Steffen Flessa Kathleen Dittmann Nils-Olaf Hübner |
| author_facet | Luise Hutzschenreuter Steffen Flessa Kathleen Dittmann Nils-Olaf Hübner |
| author_sort | Luise Hutzschenreuter |
| collection | DOAJ |
| description | Abstract Background Nosocomial infections are among the most common complications in hospitals. A major part is caused by multidrug-resistant organisms (MDRO). MRSA is still the most prominent and frequent MDRO. The early detection of carriers of multidrug-resistant bacteria is an effective measure to reduce nosocomial infections caused by MDRO. For patients who are planning to go to the hospital, an outpatient screening for MDRO and pre-hospital decolonization is recommended. However, the effectiveness of such pre-admission MDRO management in preparation for a planned hospital stay has not yet been sufficiently scientifically examined from an economic perspective. Methods A decision tree will be used to develop scenarios for MDRO screening and treatment in the context of the outpatient and inpatient sectors using MRSA-positive patients as an example. Subsequently, the expected costs for the respective strategy are presented. Results The decision tree analysis shows that the expected costs of outpatient MRSA management are €8.24 and that of inpatient MRSA management are €672.51. Conclusion The forward displacement of the MRSA screening to the ambulatory sector and any subsequent outpatient decolonization for patients with a planned hospitalization is the most cost-effective strategy and should become a standard benefit. Excluding opportunity costs, the expected costs of inpatient MRSA management are €54.94. |
| first_indexed | 2024-12-12T10:08:34Z |
| format | Article |
| id | doaj.art-6a0ede4a70d445afbddbb639e9ac60e7 |
| institution | Directory Open Access Journal |
| issn | 2047-2994 |
| language | English |
| last_indexed | 2024-12-12T10:08:34Z |
| publishDate | 2018-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Antimicrobial Resistance and Infection Control |
| spelling | doaj.art-6a0ede4a70d445afbddbb639e9ac60e72022-12-22T00:27:52ZengBMCAntimicrobial Resistance and Infection Control2047-29942018-11-01711810.1186/s13756-018-0442-xCosts of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysisLuise Hutzschenreuter0Steffen Flessa1Kathleen Dittmann2Nils-Olaf Hübner3Institute of Health Care Management, University of GreifswaldInstitute of Health Care Management, University of GreifswaldInstitute of Hygiene and Environmental Health, University Medicine of GreifswaldInstitute of Hygiene and Environmental Health, University Medicine of GreifswaldAbstract Background Nosocomial infections are among the most common complications in hospitals. A major part is caused by multidrug-resistant organisms (MDRO). MRSA is still the most prominent and frequent MDRO. The early detection of carriers of multidrug-resistant bacteria is an effective measure to reduce nosocomial infections caused by MDRO. For patients who are planning to go to the hospital, an outpatient screening for MDRO and pre-hospital decolonization is recommended. However, the effectiveness of such pre-admission MDRO management in preparation for a planned hospital stay has not yet been sufficiently scientifically examined from an economic perspective. Methods A decision tree will be used to develop scenarios for MDRO screening and treatment in the context of the outpatient and inpatient sectors using MRSA-positive patients as an example. Subsequently, the expected costs for the respective strategy are presented. Results The decision tree analysis shows that the expected costs of outpatient MRSA management are €8.24 and that of inpatient MRSA management are €672.51. Conclusion The forward displacement of the MRSA screening to the ambulatory sector and any subsequent outpatient decolonization for patients with a planned hospitalization is the most cost-effective strategy and should become a standard benefit. Excluding opportunity costs, the expected costs of inpatient MRSA management are €54.94.http://link.springer.com/article/10.1186/s13756-018-0442-xMethicillin-resistant Staphylococcus aureusOutpatient screeningDecolonizationAdmission screeningCostsExpected costs |
| spellingShingle | Luise Hutzschenreuter Steffen Flessa Kathleen Dittmann Nils-Olaf Hübner Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis Antimicrobial Resistance and Infection Control Methicillin-resistant Staphylococcus aureus Outpatient screening Decolonization Admission screening Costs Expected costs |
| title | Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis |
| title_full | Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis |
| title_fullStr | Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis |
| title_full_unstemmed | Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis |
| title_short | Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis |
| title_sort | costs of outpatient and inpatient mrsa screening and treatment strategies for patients at elective hospital admission a decision tree analysis |
| topic | Methicillin-resistant Staphylococcus aureus Outpatient screening Decolonization Admission screening Costs Expected costs |
| url | http://link.springer.com/article/10.1186/s13756-018-0442-x |
| work_keys_str_mv | AT luisehutzschenreuter costsofoutpatientandinpatientmrsascreeningandtreatmentstrategiesforpatientsatelectivehospitaladmissionadecisiontreeanalysis AT steffenflessa costsofoutpatientandinpatientmrsascreeningandtreatmentstrategiesforpatientsatelectivehospitaladmissionadecisiontreeanalysis AT kathleendittmann costsofoutpatientandinpatientmrsascreeningandtreatmentstrategiesforpatientsatelectivehospitaladmissionadecisiontreeanalysis AT nilsolafhubner costsofoutpatientandinpatientmrsascreeningandtreatmentstrategiesforpatientsatelectivehospitaladmissionadecisiontreeanalysis |